Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Tim H. H. Coorens, Grace Collord, Wanhua Lu, Emily Mitchell, Jannat Ijaz, Thomas Roberts, Thomas R. W. Oliver, G. A. Amos Burke, Michael Gattens, Emmy Dickens, Jyoti Nangalia, Marc Tischkowitz, John Anderson, Adam Shlien, Anna L. Godfrey, Matthew J. Murray, Sam Behjati

Blood (2021) 137 (21): 2992–2997.

https://doi.org/10.1182/blood.2020010150

Published: 2021

Includes: Supplemental data

Journal Articles

Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD

Blood (2019) 134 (19): 1670–1682.

https://doi.org/10.1182/blood.2019001950

Published: 2019

Journal Articles

GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells

Brent H. Koehn, Petya Apostolova, Jessica M. Haverkamp, Jeffrey S. Miller, Valarie McCullar, Jakub Tolar, David H. Munn, William J. Murphy, Willie June Brickey, Jonathan S. Serody, Dmitry I. Gabrilovich, Vincenzo Bronte, Peter J. Murray, Jenny P.-Y. Ting, Robert Zeiser, Bruce R. Blazar

Blood (2015) 126 (13): 1621–1628.

https://doi.org/10.1182/blood-2015-03-634691

Published: 2015

Includes: Supplemental data

Journal Articles

Full Donor T Cell Chimerism Predicts Transplant Outcomes In High Risk AML But Not In Intermediate Risk AML After a T-Deplete Alemtuzumab Conditioned Transplant

Amy Gudger, Vidhya Murthy, Duncan J Murray, MA MRCP, Ben Bailiff, Maria Mushkbar, Jonathan ray Lancashire, MBBS, MRCP, Phillip Nicolson, Kathy Holder, Lynda Baker, Lynn Bratby, Bhuvan Kishore, Richard Lovell, Shankaranarayana Paneesha, Nikolousis Emmanouil, MRCP, FRCPath, Ph.D

Blood (2013) 122 (21): 5545.

https://doi.org/10.1182/blood.V122.21.5545.5545

Published: 2013

Journal Articles

Acute Myeloid Leukemia: Low Peripheral Blast Count May Predict Better Outcome with Best Supportive Care Than with Intensive Chemotherapy in Older Patients

Duncan J Murray, MA MRCP, Jhansi Muddana, MD MRCP FRCPath, Anton Borg, MD, FRCP, FRCPath, Beth D Harrison, MA DM FRCP FRCPath

Blood (2012) 120 (21): 3550.

https://doi.org/10.1182/blood.V120.21.3550.3550

Published: 2012

Journal Articles

STAT3 controls myeloid progenitor growth during emergency granulopoiesis

Huiyuan Zhang, Hoainam Nguyen-Jackson, Athanasia D. Panopoulos, Haiyan S. Li, Peter J. Murray, Stephanie S. Watowich

Blood (2010) 116 (14): 2462–2471.

https://doi.org/10.1182/blood-2009-12-259630

Published: 2010

Journal Articles

STAT3 Controls Neutrophil Progenitor Growth and Differentiation During Emergency Granulopoiesis.

Huiyuan Zhang, Hoainam Nguyen-Jackson, Athanasia Panopoulos, Haiyan S Li, Peter J Murray, Stephanie Watowich, PhD

Blood (2009) 114 (22): 3619.

https://doi.org/10.1182/blood.V114.22.3619.3619

Published: 2009

Journal Articles

Drug Rediscovery: Glybenclamide Exhibits Thromboxane Receptor-Dependent Antithrombotic Activity.

Harold J. Ting, BsC, Wallace J. Murray, PhD, Fadi T. Khasawneh, BPharm, PhD

Blood (2009) 114 (22): 2994.

https://doi.org/10.1182/blood.V114.22.2994.2994

Published: 2009

Journal Articles

Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

Mohamed Lamkanfi, Lilian O. Moreira, Patrudu Makena, Diana C. J. Spierings, Kelli Boyd, Peter J. Murray, Douglas R. Green, Thirumala-Devi Kanneganti

Blood (2009) 113 (12): 2742–2745.

https://doi.org/10.1182/blood-2008-09-178038

Published: 2009

Journal Articles

STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils

Athanasia D. Panopoulos, Ling Zhang, Jonathan W. Snow, Daniel M. Jones, Amber M. Smith, Karim C. El Kasmi, Fulu Liu, Mark A. Goldsmith, Daniel C. Link, Peter J. Murray, Stephanie S. Watowich

Blood (2006) 108 (12): 3682–3690.

https://doi.org/10.1182/blood-2006-02-003012

Published: 2006

Journal Articles

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Amy D. Klion, MD, Marc E. Rothenberg, MD, PhD, John J. Murray, MD,PhD, Anish Singh, MD, PhD, Hans-Uwe Simon, MD,PhD

Blood (2006) 108 (11): 2694.

https://doi.org/10.1182/blood.V108.11.2694.2694

Published: 2006

Journal Articles

Long-Term and Sustained Correction of the α-Galactosidase A Deficiency in Fabry Mice and Patient Cells Receiving Lentivirally Transduced Hematopoietic Stem/Progenitor Cells.

Makoto Yoshimitsu, MD, Christopher Siatskas, PhD, Sheng-Ben Liang, MD, PhD, Vanessa I. Rasaiah, Koji Higuchi, MD, Gary J. Murray, PhD, Toshihiro Takenaka, MD, PhD, Chuwa Tei, MD, PhD, Roscoe O. Brady, MD, Jeffrey A. Medin, PhD

Blood (2005) 106 (11): 1285.

https://doi.org/10.1182/blood.V106.11.1285.1285

Published: 2005

Journal Articles

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen, Theresa J. Ngai, Sharianne G. Louie, Kevin W. H. Yee, Lily M. Wong, Weiru Hong, Leslie B. Lee, Ajia Town, Beverly D. Smolich, William C. Manning, Lesley J. Murray, Michael C. Heinrich, Julie M. Cherrington

Blood (2003) 101 (9): 3597–3605.

https://doi.org/10.1182/blood-2002-07-2307

Published: 2003

Journal Articles

Hematopoietic Remodeling in Interferon-γ–Deficient Mice Infected With Mycobacteria

Peter J. Murray, Richard A. Young, George Q. Daley

Blood (1998) 91 (8): 2914–2924.

https://doi.org/10.1182/blood.V91.8.2914.2914_2914_2924

Published: 1998

Journal Articles

Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34 + Thy-1 + Lin − Cells With Preserved Ability to Engraft SCID-hu Bone

Karin M. Luens, Marilyn A. Travis, Ben P. Chen, Beth L. Hill, Roland Scollay, Lesley J. Murray

Blood (1998) 91 (4): 1206–1215.

https://doi.org/10.1182/blood.V91.4.1206

Published: 1998

Journal Articles

Characterization of the Underlying Molecular Defect in Hereditary Spherocytosis Associated With Spectrin Deficiency

H. Hassoun, J.N. Vassiliadis, J. Murray, P.R. Njolstad, John J. Rogus, S.K. Ballas, F. Schaffer, P. Jarolim, V. Brabec, J. Palek

Blood (1997) 90 (1): 398–406.

https://doi.org/10.1182/blood.V90.1.398

Published: 1997

Journal Articles

Hereditary spherocytosis with spectrin deficiency due to an unstable truncated beta spectrin

H Hassoun, JN Vassiliadis, J Murray, SJ Yi, M Hanspal, CA Johnson, J Palek

Blood (1996) 87 (6): 2538–2545.

https://doi.org/10.1182/blood.V87.6.2538.bloodjournal8762538

Published: 1996

Journal Articles

HYPOPLASTIC ANEMIA DUE TO ATABRINE

ALFRED P. FISHMAN, M.D., J. MURRAY KINSMAN, M.D.

Blood (1949) 4 (8): 970–976.

https://doi.org/10.1182/blood.V4.8.970.970

Published: 1949

NARROW

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD

GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells

Full Donor T Cell Chimerism Predicts Transplant Outcomes In High Risk AML But Not In Intermediate Risk AML After a T-Deplete Alemtuzumab Conditioned Transplant

Acute Myeloid Leukemia: Low Peripheral Blast Count May Predict Better Outcome with Best Supportive Care Than with Intensive Chemotherapy in Older Patients

STAT3 controls myeloid progenitor growth during emergency granulopoiesis

STAT3 Controls Neutrophil Progenitor Growth and Differentiation During Emergency Granulopoiesis.

Drug Rediscovery: Glybenclamide Exhibits Thromboxane Receptor-Dependent Antithrombotic Activity.

Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Long-Term and Sustained Correction of the α-Galactosidase A Deficiency in Fabry Mice and Patient Cells Receiving Lentivirally Transduced Hematopoietic Stem/Progenitor Cells.

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Hematopoietic Remodeling in Interferon-γ–Deficient Mice Infected With Mycobacteria

Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34 + Thy-1 + Lin − Cells With Preserved Ability to Engraft SCID-hu Bone

Characterization of the Underlying Molecular Defect in Hereditary Spherocytosis Associated With Spectrin Deficiency

Hereditary spherocytosis with spectrin deficiency due to an unstable truncated beta spectrin

HYPOPLASTIC ANEMIA DUE TO ATABRINE

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only